Loading...
Switching to an Infliximab Biosimilar Was Safe and Effective in Dutch Sarcoidosis Patients
The effect of switching from originator infliximab to biosimilar infliximab in patients with sarcoidosis is unknown. The objective of this study is to investigate the effect of switching from Remicade(®) or Inflectra(®) to Flixabi(®) in patients with severe refractory sarcoidosis. This single center...
Na minha lista:
| Udgivet i: | Cells |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7922542/ https://ncbi.nlm.nih.gov/pubmed/33669641 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells10020441 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|